Cancer

  • Yang C, Zheng S, Liu T, Liu Q, Dai F, Zhou J, Chen Y, Sheyhidin I, Lu X. Down-regulated miR-26a promotes proliferation, migration, and invasion via negative regulation of MTDH in esophageal squamous cell carcinoma. FASEB J. 2017 Feb 7. pii: fj.201601237. doi: 10.1096/fj.201601237. PubMed 28174206 DOI http://dx.doi.org/10.1096/fj.201601237
  • He C, Wang L, Zhang J, Xu H. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer. Mol Cancer. 2017 Feb 7;16(1):35. doi: 10.1186/s12943-017-0603-1. PubMed 28173803 DOI http://dx.doi.org/10.1186/s12943-017-0603-1
  • Fane M, Harris L, Smith AG, Piper M. Nuclear Factor One transcription factors as epigenetic regulators in cancer. Int J Cancer. 2017 Jan 11. doi: 10.1002/ijc.30603. PubMed 28076901 DOI http://dx.doi.org/10.1002/ijc.30603
  • Chao HM, Huang HX, Chang PH, Tseng KC, Miyajima A, Chern E. Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt/beta-catenin pathway. Oncotarget. 2017 Jan 10;8(2):2604-2616. doi: 10.18632/oncotarget.13733. PubMed 27911878 DOI http://dx.doi.org/10.18632/oncotarget.13733
  • Xiang J, Fu X, Ran W, Wang Z. Grhl2 reduces invasion and migration through inhibition of TGFbeta-induced EMT in gastric cancer. Oncogenesis. 2017 Jan 9;6(1):e284. doi: 10.1038/oncsis.2016.83. PubMed 28067907 DOI http://dx.doi.org/10.1038/oncsis.2016.83
  • Norita R, Suzuki Y, Furutani Y, Takahashi K, Yoshimatsu Y, Podyma-Inoue KA, Watabe T, Sato Y. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating TGF-beta signaling. Cancer Sci. 2017 Jan 8. doi: 10.1111/cas.13157. PubMed 28064471 DOI http://dx.doi.org/10.1111/cas.13157
  • Xu W, Chang J, Liu G, Du X, Li X. Knockdown of FOXR2 suppresses the tumorigenesis, growth and metastasis of prostate cancer. Biomed Pharmacother. 2017 Jan 6;87:471-475. doi: 10.1016/j.biopha.2016.12.120. PubMed 28068638 DOI http://dx.doi.org/10.1016/j.biopha.2016.12.120
  • Diaz-Vera J, Palmer S, Hernandez-Fernaud JR, Dornier E, Mitchell LE, Macpherson I, Edwards J, Zanivan S, Norman JC. A proteomic approach to identify endosomal cargoes controlling cancer invasiveness. J Cell Sci. 2017 Jan 6. pii: jcs.190835. doi: 10.1242/jcs.190835. PubMed 28062852 DOI http://dx.doi.org/10.1242/jcs.190835
  • Shi X, Li D, Wang Y, Liu S, Qin J, Wang J, Ran J, Zhang Y, Huang Q, Liu X, Zhou J, Liu M. Discovery of Centrosomal Protein 70 as an Important Player in the Development and Progression of Breast Cancer. Am J Pathol. 2017 Jan 5. pii: S0002-9440(16)30523-5. doi:, 10.1016/j.ajpath.2016.11.005. PubMed 28063737 DOI http://dx.doi.org/10.1016/j.ajpath.2016.11.005
  • Nandi P, Girish GV, Majumder M, Xin X, Tutunea-Fatan E, Lala PK. PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells. BMC Cancer. 2017 Jan 5;17(1):11. doi: 10.1186/s12885-016-3018-2. PubMed 28056899 DOI http://dx.doi.org/10.1186/s12885-016-3018-2
  • Benzina S, Beauregard AP, Guerrette R, Jean S, Faye MD, Laflamme M, Maicas E, Crapoulet N, Ouellette RJ, Robichaud GA. Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processes. Oncotarget. 2017 Jan 5. doi: 10.18632/oncotarget.14511. PubMed 28076843 DOI http://dx.doi.org/10.18632/oncotarget.14511
  • Zhang X, Cai L, Zhang G, Shen Y, Huang J. B7-H4 promotes tumor growth and metastatic progression in lung cancer by impacting cell proliferation and survival. Oncotarget. 2017 Jan 3. doi: 10.18632/oncotarget.14475. PubMed 28061481 DOI http://dx.doi.org/10.18632/oncotarget.14475
  • Chen P, Zuo H, Xiong H, Kolar MJ, Chu Q, Saghatelian A, Siegwart DJ, Wan Y. Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis. Proc Natl Acad Sci U S A. 2017 Jan 3. pii: 201614035. doi:, 10.1073/pnas.1614035114. PubMed 28049847 DOI http://dx.doi.org/10.1073/pnas.1614035114
  • Piccolella M, Crippa V, Cristofani R, Rusmini P, Galbiati M, Elena Cicardi M, Meroni M, Ferri N, Morelli FF, Carra S, Messi E, Poletti A. The small heat shock protein B8 (HSPB8) modulates proliferation and migration of breast cancer cells. Oncotarget. 2017 Jan 2. doi: 10.18632/oncotarget.14422. PubMed 28060751 DOI http://dx.doi.org/10.18632/oncotarget.14422
  • Indovina P, Casini N, Forte IM, Garofano T, Cesari D, Iannuzzi CA, Del Porro L, Pentimalli F, Napoliello L, Boffo S, Schenone S, Botta M, Giordano A. SRC Family Kinase Inhibition in Ewing Sarcoma Cells Induces p38 MAP Kinase-Mediated Cytotoxicity and Reduces Cell Migration. J Cell Physiol. 2017 Jan;232(1):129-35. doi: 10.1002/jcp.25397. Epub 2016 Apr 19. PubMed 27037775 DOI http://dx.doi.org/10.1002/jcp.25397
  • Manerba M, Di Ianni L, Govoni M, Roberti M, Recanatini M, Di Stefano G. Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells. Eur J Pharm Sci. 2017 Jan 1;96:37-44. doi: 10.1016/j.ejps.2016.09.014. Epub 2016 , Sep 10. PubMed 27622920 DOI http://dx.doi.org/10.1016/j.ejps.2016.09.014
  • Zhou T, Li Y, Yang L, Liu L, Ju Y, Li C. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells. Oncol Rep. 2017 Jan;37(1):388-398. doi: 10.3892/or.2016.5251. Epub 2016 Nov 16. PubMed 27878264 DOI http://dx.doi.org/10.3892/or.2016.5251
  • Sun W, Guo L, Shao G, Liu X, Guan Y, Su L, Zhao S. Suppression of LASP-1 attenuates the carcinogenesis of prostatic cancer cell lines: Key role of the NF-kappaB pathway. Oncol Rep. 2017 Jan;37(1):341-347. doi: 10.3892/or.2016.5223. Epub 2016 Nov 7. PubMed 27840958 DOI http://dx.doi.org/10.3892/or.2016.5223
  • Annabi B, Zgheib A, Annabi B. Cavin-2 Functions as a Suppressive Regulator in TNF-induced Mesenchymal Stromal Cell Inflammation and Angiogenic Phenotypes. Int J Stem Cells. 2016 Dec 31. doi: 10.15283/ijsc16032. PubMed 28024316 DOI http://dx.doi.org/10.15283/ijsc16032
  • Kim R, Park SI, Lee CY, Lee J, Kim P, Oh S, Lee H, Lee MY, Kim J, Chung YA, Hwang KC, Maeng LS, Chang W. Alternative new mesenchymal stem cell source exerts tumor tropism through ALCAM and N-cadherin via regulation of microRNA-192 and -218. Mol Cell Biochem. 2016 Dec 30. doi: 10.1007/s11010-016-2909-5. PubMed 28039611 DOI http://dx.doi.org/10.1007/s11010-016-2909-5
  • Lin SZ, Li B, Xu GK, Feng XQ. Collective dynamics of cancer cells confined in a confluent monolayer of normal cells. J Biomech. 2016 Dec 29. pii: S0021-9290(16)31328-8. doi:, 10.1016/j.jbiomech.2016.12.035. PubMed 28063647 DOI http://dx.doi.org/10.1016/j.jbiomech.2016.12.035
  • Dai Y, Wang M, Wu H, Xiao M, Liu H, Zhang D. Loss of FOXN3 in colon cancer activates beta-catenin/TCF signaling and promotes the growth and migration of cancer cells. Oncotarget. 2016 Dec 26. doi: 10.18632/oncotarget.14189. PubMed 28039460 DOI http://dx.doi.org/10.18632/oncotarget.14189
  • Maolake A, Izumi K, Shigehara K, Natsagdorj A, Iwamoto H, Kadomoto S, Takezawa Y, Machioka K, Narimoto K, Namiki M, Lin WJ, Wufuer G, Mizokami A. Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22-CCR4 axis. Oncotarget. 2016 Dec 26. doi: 10.18632/oncotarget.14185. PubMed 28039457 DOI http://dx.doi.org/10.18632/oncotarget.14185
  • Boylan KL, Buchanan PC, Manion RD, Shukla DM, Braumberger K, Bruggemeyer C, Skubitz AP. The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate. Oncotarget. 2016 Dec 25. doi: 10.18632/oncotarget.14206. PubMed 28038455 DOI http://dx.doi.org/10.18632/oncotarget.14206
  • Salvatore V, Teti G, Focaroli S, Mazzotti MC, Mazzotti A, Falconi M. The tumor microenvironment promotes cancer progression and cell migration. Oncotarget. 2016 Dec 24. doi: 10.18632/oncotarget.14155. PubMed 28030810 DOI http://dx.doi.org/10.18632/oncotarget.14155
  • Blockhuys S, Wittung-Stafshede P. Copper chaperone Atox1 plays role in breast cancer cell migration. Biochem Biophys Res Commun. 2016 Dec 24. pii: S0006-291X(16)32208-2. doi:, 10.1016/j.bbrc.2016.12.148. PubMed 28027931 DOI http://dx.doi.org/10.1016/j.bbrc.2016.12.148
  • Zhang D, Jin N, Sun W, Li X, Liu B, Xie Z, Qu J, Xu J, Yang X, Su Y, Tang S, Han H, Chen D, Ding J, Tan M, Huang M, Geng M. Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity. Oncogene. 2016 Dec 19. doi: 10.1038/onc.2016.446. PubMed 27991922 DOI http://dx.doi.org/10.1038/onc.2016.446
  • Jiang C, Zhu Y, Zhou Z, Gumin J, Bengtsson L, Wu W, Songyang Z, Lang FF, Lin X. TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-kappaB activation and tumor progression. Oncogene. 2016 Dec 19. doi: 10.1038/onc.2016.430. PubMed 27991920 DOI http://dx.doi.org/10.1038/onc.2016.430
  • Li JJ, Sun ZJ, Yuan YM, Yin FF, Bian YG, Long LY, Zhang XL, Xie D. Thyroid cancer: EphB3 stimulates cell migration and metastasis in a kinase-dependent manner through Vav2-Rho GTPase Axis. J Biol Chem. 2016 Dec 16. pii: jbc.M116.750349. PubMed 27986811 DOI http://dx.doi.org/10.1074/jbc.M116.750349
  • Li N, Xie C, Lu N. Crosstalk between Hippo signalling and miRNAs in tumour progression. FEBS J. 2016 Dec 14. doi: 10.1111/febs.13985. PubMed 27973704 DOI http://dx.doi.org/10.1111/febs.13985